Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population.

Guella I, Asselta R, Ardissino D, Merlini PA, Peyvandi F, Kathiresan S, Mannucci PM, Tubaro M, Duga S.

J Lipid Res. 2010 Nov;51(11):3342-9. doi: 10.1194/jlr.M010009. Epub 2010 Aug 10.

2.

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.

Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A.

J Am Coll Cardiol. 2010 Jun 22;55(25):2833-42. doi: 10.1016/j.jacc.2010.02.044. Review.

3.

Further LDL cholesterol lowering through targeting PCSK9 for coronary artery disease.

Cao G, Qian YW, Kowala MC, Konrad RJ.

Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):238-43. Review.

PMID:
19075777
4.

Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia.

Maxwell KN, Breslow JL.

Curr Opin Lipidol. 2005 Apr;16(2):167-72. Review.

PMID:
15767856
5.

Molecular biology of PCSK9: its role in LDL metabolism.

Horton JD, Cohen JC, Hobbs HH.

Trends Biochem Sci. 2007 Feb;32(2):71-7. Epub 2007 Jan 9. Review.

6.

Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.

Abifadel M, Rab├Ęs JP, Devillers M, Munnich A, Erlich D, Junien C, Varret M, Boileau C.

Hum Mutat. 2009 Apr;30(4):520-9. doi: 10.1002/humu.20882. Review.

PMID:
19191301
7.

Genetic susceptibility to myocardial infarction and coronary artery disease.

Topol EJ, Smith J, Plow EF, Wang QK.

Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R117-23. Review.

PMID:
16987874
8.

The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis.

Mousavi SA, Berge KE, Leren TP.

J Intern Med. 2009 Dec;266(6):507-19. doi: 10.1111/j.1365-2796.2009.02167.x. Review.

9.

PCSK9 and LDL cholesterol: unravelling the target to design the bullet.

Costet P, Krempf M, Cariou B.

Trends Biochem Sci. 2008 Sep;33(9):426-34. doi: 10.1016/j.tibs.2008.06.005. Epub 2008 Jul 30. Review.

PMID:
18672372
10.

Progress in unraveling the genetics of coronary artery disease and myocardial infarction.

Anderson JL, Carlquist JF, Horne BD, Hopkins PN.

Curr Atheroscler Rep. 2007 Sep;9(3):179-86. Review.

PMID:
18241611
11.

A genetic basis for coronary artery disease.

Roberts R.

Trends Cardiovasc Med. 2015 Apr;25(3):171-8. doi: 10.1016/j.tcm.2014.10.008. Epub 2014 Oct 17. Review.

PMID:
25453988
12.

Sortilin, encoded by the cardiovascular risk gene SORT1, and its suggested functions in cardiovascular disease.

Kjolby M, Nielsen MS, Petersen CM.

Curr Atheroscler Rep. 2015 Apr;17(4):496. doi: 10.1007/s11883-015-0496-7. Review.

PMID:
25702058
13.

The role of genetic risk factors in coronary artery disease.

Dandona S, Roberts R.

Curr Cardiol Rep. 2014 May;16(5):479. doi: 10.1007/s11886-014-0479-2. Review.

PMID:
24691635

Supplemental Content

Support Center